Analyst Reco. Zimmer Biomet Holdings, Inc. London S.E.

Equities

0QQD

US98956P1021

Market Closed - London S.E. Other stock markets 14:41:26 29/01/2021 GMT			5-day change	1st Jan Change
136.1 ^CHF	+6.20%		-.--%	-.--%

06-20	Zimmer Biomet Holdings, Inc. Appoints Devdatt Kurdikar to its Board of Directors	CI
06-12	Zimmer Biomet Enters Co-Marketing Deal With RevelAi Health	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Zimmer Biomet Holdings Insider Sold Shares Worth $1,474,582, According to a Recent SEC Filing	06-04	MT
Barclays Adjusts Price Target on Zimmer Biomet to $125 From $130	05-31	MT
Barclays Adjusts Price Target on Zimmer Biomet Holdings to $125 From $130	05-31	MT
Argus Upgrades Zimmer Biomet to Buy From Hold With $150 Price Target	05-21	MT
Raymond James Adjusts Price Target on Zimmer Biomet Holdings to $138 From $142	05-03	MT
UBS Adjusts Price Target on Zimmer Biomet Holdings to $112 From $109, Maintains Sell Rating	05-03	MT
Truist Adjusts Zimmer Biomet Holdings' PT to $130 From $137, Keeps Hold Rating	05-03	MT
Bernstein Adjusts Price Target on Zimmer Biomet to $133 From $132	05-03	MT
Jefferies Adjusts Price Target on Zimmer Biomet to $135 From $136	05-03	MT
Citigroup Adjusts Price Target on Zimmer Biomet to $134 From $140	05-03	MT
Morgan Stanley Adjusts Price Target on Zimmer Biomet to $130 From $135	05-03	MT
Jefferies Adjusts Zimmer Biomet Price Target to $135 From $136	05-03	MT
Citigroup Adjusts Zimmer Biomet Price Target to $134 From $140	05-03	MT
Morgan Stanley Adjusts Zimmer Biomet Price Target to $130 From $135	05-03	MT
Oppenheimer Adjusts Price Target on Zimmer Biomet Holdings to $155 From $150	05-03	MT
BTIG Adjusts Price Target on Zimmer Biomet to $139 From $138, Keeps Buy Rating	05-02	MT
Truist Securities Adjusts Zimmer Biomet Price Target to $137 From $135, Hold Rating Kept	04-15	MT
Citigroup Raises Price Target on Zimmer Biomet to $140 From $134, Keeps Neutral Rating	04-03	MT
UBS Adjusts Zimmer Biomet Price Target to $109 From $105, Maintains Sell Rating	02-09	MT
Deutsche Bank Adjusts Zimmer Biomet Price Target to $140 From $147, Maintains Hold Rating	02-09	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Zimmer Biomet Holdings, Inc. London S.E.

Equities

0QQD

US98956P1021

Analyst Reco.

Filters